AstraZeneca begins new COVID-19 prevention trials of antibody cocktail
LONDON (Reuters) – AstraZenecaAZN.L began late-stage trials on Saturday of an experimental long-acting monoclonal antibody mixture drug it hopes may…
Read MoreFrom here and there
LONDON (Reuters) – AstraZenecaAZN.L began late-stage trials on Saturday of an experimental long-acting monoclonal antibody mixture drug it hopes may…
Read More